<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We previously demonstrated the presence of two different populations among individuals with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>: those having either a high titer or a low titer of antibodies to GAD (GADAs) </plain></SENT>
<SENT sid="1" pm="."><plain>Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) has been identified as a new susceptibility gene for type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and other <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the present study was to evaluate whether the phenotypic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> based on the GADA titer is associated with the PTPN22 C1858T polymorphism </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: Analysis for the C1858T polymorphism using the TaqMan assay was performed in 250 subjects with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>, divided into two subgroups with low (&lt;or=32 arbitrary units) or high (&gt;32 arbitrary units) GADA titers and 450 subjects with classic type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (from the Non Insulin Requiring Autoimmune <z:mp ids='MP_0002055'>Diabetes</z:mp> [NIRAD] Study cohort of 5,330 subjects with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp>) and in 558 subjects with <z:hpo ids='HP_0003621'>juvenile-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and 545 normoglycemic subjects </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Genotype, allele, and phenotype distributions of the PTPN22 C1858T variant revealed similar frequencies in autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> with high GADA titer and <z:hpo ids='HP_0003621'>juvenile-onset</z:hpo> type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>An increase in TT and CT genotypes was observed in individuals with a high GADA titer compared with a low GADA titer, those with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and control subjects (P &lt; 0.002 for <z:hpo ids='HP_0000001'>all</z:hpo> comparisons) </plain></SENT>
<SENT sid="6" pm="."><plain>The PTPN22 1858T allele and phenotype frequencies were increased in high GADA titer compared with a low GADA titer, type 2 diabetic, and control subjects (P &lt; 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo> comparisons, odds ratio 2.6) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp>, the PTPN22 1858T variant is associated only with a high GADA titer, providing evidence of a genetic background to clinical <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> identified by GADA titer </plain></SENT>
</text></document>